• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种简单的共识方法可提高体细胞突变预测准确性。

A simple consensus approach improves somatic mutation prediction accuracy.

机构信息

Peter MacCallum Cancer Centre, Sarcoma Genetics and Genomics Laboratory, St. Andrew's Place, East Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.

Peter MacCallum Cancer Centre, Cancer Genetics Laboratory, St. Andrew's Place, East Melbourne, Victoria, Australia.

出版信息

Genome Med. 2013 Sep 30;5(9):90. doi: 10.1186/gm494. eCollection 2013.

DOI:10.1186/gm494
PMID:24073752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3978449/
Abstract

Differentiating true somatic mutations from artifacts in massively parallel sequencing data is an immense challenge. To develop methods for optimal somatic mutation detection and to identify factors influencing somatic mutation prediction accuracy, we validated predictions from three somatic mutation detection algorithms, MuTect, JointSNVMix2 and SomaticSniper, by Sanger sequencing. Full consensus predictions had a validation rate of >98%, but some partial consensus predictions validated too. In cases of partial consensus, read depth and mapping quality data, along with additional prediction methods, aided in removing inaccurate predictions. Our consensus approach is fast, flexible and provides a high-confidence list of putative somatic mutations.

摘要

从大规模平行测序数据中区分真实的体细胞突变和伪像极具挑战性。为了开发最佳体细胞突变检测方法,并确定影响体细胞突变预测准确性的因素,我们通过 Sanger 测序对三种体细胞突变检测算法(MuTect、JointSNVMix2 和 SomaticSniper)的预测结果进行了验证。完全一致的预测验证率>98%,但部分一致的预测也有一些得到了验证。在部分一致的情况下,通过增加读深度和映射质量数据以及额外的预测方法,可以帮助去除不准确的预测。我们的一致方法快速、灵活,并提供了一组高可信度的疑似体细胞突变列表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de04/3978449/5e1fd3326c8d/gm494-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de04/3978449/973df1e11192/gm494-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de04/3978449/5e1fd3326c8d/gm494-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de04/3978449/973df1e11192/gm494-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de04/3978449/5e1fd3326c8d/gm494-2.jpg

相似文献

1
A simple consensus approach improves somatic mutation prediction accuracy.一种简单的共识方法可提高体细胞突变预测准确性。
Genome Med. 2013 Sep 30;5(9):90. doi: 10.1186/gm494. eCollection 2013.
2
SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.SNVSniffer:一种用于种系和体细胞单核苷酸及插入缺失突变的综合检测工具。
BMC Syst Biol. 2016 Aug 1;10 Suppl 2(Suppl 2):47. doi: 10.1186/s12918-016-0300-5.
3
Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data.基于特征的分类器用于肿瘤-正常配对测序数据中的体细胞突变检测。
Bioinformatics. 2012 Jan 15;28(2):167-75. doi: 10.1093/bioinformatics/btr629. Epub 2011 Nov 13.
4
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.一种计算方法,用于从无匹配正常样本的癌症标本深度测序中区分基因组改变的体细胞起源与种系起源。
PLoS Comput Biol. 2018 Feb 7;14(2):e1005965. doi: 10.1371/journal.pcbi.1005965. eCollection 2018 Feb.
5
In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data.基于不同肿瘤下一代测序深度数据的体细胞点突变检测工具的深入比较。
Sci Rep. 2016 Nov 22;6:36540. doi: 10.1038/srep36540.
6
Somatic mutation detection efficiency in EGFR: a comparison between high resolution melting analysis and Sanger sequencing.在 EGFR 中检测体细胞突变的效率:高分辨率熔解分析与 Sanger 测序的比较。
BMC Cancer. 2020 Sep 22;20(1):902. doi: 10.1186/s12885-020-07411-1.
7
Evaluating somatic tumor mutation detection without matched normal samples.评估无配对正常样本的体细胞肿瘤突变检测。
Hum Genomics. 2017 Sep 4;11(1):22. doi: 10.1186/s40246-017-0118-2.
8
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.评估九种体细胞变异检测工具在全外显子组测序和靶向深度测序数据中检测体细胞突变的性能
PLoS One. 2016 Mar 22;11(3):e0151664. doi: 10.1371/journal.pone.0151664. eCollection 2016.
9
A comparative analysis of algorithms for somatic SNV detection in cancer.癌症体细胞单核苷酸变异检测算法的比较分析。
Bioinformatics. 2013 Sep 15;29(18):2223-30. doi: 10.1093/bioinformatics/btt375. Epub 2013 Jul 9.
10
Detection of genome-wide low-frequency mutations with Paired-End and Complementary Consensus Sequencing (PECC-Seq) revealed end-repair-derived artifacts as residual errors.采用 Paired-End 和 Complementary Consensus Sequencing(PECC-Seq)检测全基因组低频突变,揭示末端修复衍生的伪迹作为残留错误。
Arch Toxicol. 2020 Oct;94(10):3475-3485. doi: 10.1007/s00204-020-02832-0. Epub 2020 Jul 31.

引用本文的文献

1
Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository dataset.神经纤维瘤病1型相关周围神经鞘瘤的综合基因组分析:更新的生物样本库数据集
Sci Data. 2025 Jul 15;12(1):1229. doi: 10.1038/s41597-025-05433-7.
2
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing.全外显子组测序中个体体细胞变异检测工具及基于投票的集成方法的基准研究
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae697.
3
A Novel Affordable and Reliable Framework for Accurate Detection and Comprehensive Analysis of Somatic Mutations in Cancer.

本文引用的文献

1
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.检测不纯和异质癌症样本中的体细胞点突变。
Nat Biotechnol. 2013 Mar;31(3):213-9. doi: 10.1038/nbt.2514. Epub 2013 Feb 10.
2
A survey of tools for variant analysis of next-generation genome sequencing data.下一代基因组测序数据变异分析工具综述。
Brief Bioinform. 2014 Mar;15(2):256-78. doi: 10.1093/bib/bbs086. Epub 2013 Jan 21.
3
Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.全外显子组测序揭示癌症中反复出现的体细胞突变网络。
一种新型的经济实惠且可靠的框架,用于准确检测和全面分析癌症中的体细胞突变。
Int J Mol Sci. 2024 Jul 24;25(15):8044. doi: 10.3390/ijms25158044.
4
Prediction of Deleterious Single Amino Acid Polymorphisms with a Consensus Holdout Sampler.使用一致性留出采样器预测有害单氨基酸多态性
Curr Genomics. 2024 May 31;25(3):171-184. doi: 10.2174/0113892029236347240308054538. Epub 2024 Mar 14.
5
Transformers meets neoantigen detection: a systematic literature review.变压器与新抗原检测:系统文献综述。
J Integr Bioinform. 2024 Jul 4;21(2). doi: 10.1515/jib-2023-0043. eCollection 2024 Jun 1.
6
Simple combination of multiple somatic variant callers to increase accuracy.多种体细胞变异 caller 的简单组合可提高准确性。
Sci Rep. 2023 May 25;13(1):8463. doi: 10.1038/s41598-023-34925-y.
7
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.通过检测富集的白血病原始细胞而非急性髓系白血病患者的单核细胞,可改善预后表达生物标志物的验证。
Biomark Res. 2023 Mar 16;11(1):31. doi: 10.1186/s40364-023-00461-0.
8
Computational cancer neoantigen prediction: current status and recent advances.计算性癌症新抗原预测:现状与最新进展
Immunooncol Technol. 2021 Nov 20;12:100052. doi: 10.1016/j.iotech.2021.100052. eCollection 2021 Dec.
9
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.利用ELN-2017指南及其他预后因素的急性髓系白血病风险分层模型:一项SWOG报告
Biomark Res. 2020 Aug 12;8:29. doi: 10.1186/s40364-020-00208-1. eCollection 2020.
10
SomaticCombiner: improving the performance of somatic variant calling based on evaluation tests and a consensus approach.SomaticCombiner:基于评估测试和共识方法提高体细胞变异calling 的性能。
Sci Rep. 2020 Jul 30;10(1):12898. doi: 10.1038/s41598-020-69772-8.
Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12.
4
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.对浆液性子宫内膜肿瘤的外显子组测序鉴定出染色质重塑和泛素连接酶复合物基因中的反复发生的体细胞突变。
Nat Genet. 2012 Dec;44(12):1310-5. doi: 10.1038/ng.2455. Epub 2012 Oct 28.
5
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.RNF43 是一种抑癌基因,在卵巢黏液性肿瘤中发生突变。
J Pathol. 2013 Feb;229(3):469-76. doi: 10.1002/path.4134.
6
Confidence-based somatic mutation evaluation and prioritization.基于置信度的体细胞突变评估和优先级排序。
PLoS Comput Biol. 2012;8(9):e1002714. doi: 10.1371/journal.pcbi.1002714. Epub 2012 Sep 27.
7
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
8
Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.术前卵巢黏液性肿瘤的特征是 CDKN2A 和 RAS 通路异常。
Clin Cancer Res. 2012 Oct 1;18(19):5267-77. doi: 10.1158/1078-0432.CCR-12-1103. Epub 2012 Aug 13.
9
Evolution and functional impact of rare coding variation from deep sequencing of human exomes.人类外显子组深度测序中罕见编码变异的进化和功能影响。
Science. 2012 Jul 6;337(6090):64-9. doi: 10.1126/science.1219240. Epub 2012 May 17.
10
Reliable detection of subclonal single-nucleotide variants in tumour cell populations.可靠检测肿瘤细胞群体中的亚克隆单核苷酸变异。
Nat Commun. 2012 May 1;3:811. doi: 10.1038/ncomms1814.